Skip to content
Review

Recent strategies and approaches for the development of molecularly targeted nanomedicine.

2026 · Advances in Protein Chemistry and Structural Biology · Vol 153, pp. 1-57 · 0 citations
Medicine

TL;DR

This chapter highlights the role of targeting ligands, stimuli-responsive systems, and tumor microenvironment-specific strategies in enhancing therapeutic efficacy while minimizing adverse effects, emphasizing the potential of molecularly targeted nanomedicine to advance precision therapy and improve clinical outcomes.

View source

Similar papers

Review Open access Aug 2026

Cancer Nanomedicine: Advanced Nanocarrier Systems, Targeted Drug Delivery, Theranostics, and Emerging Strategies for Precision Oncology

Overall, cancer nanomedicine has evolved from a simple drug-delivery concept into a multifunctional therapeutic platform integrating targeted therapy, molecular imaging, immunomodulation, gene therapy, and personalized medicine.

Fouzan Arif Mulla Mulla, M. Khan, Irfan Nizamuddin Mansuri Mansuri et al. · 0 citations
Open access Sep 2026

Innovative nanomedicine strategies for precision-controlled targeted drug delivery: recent preclinical progress

Current preclinical evidence supports nanomedicine as a central pillar of precision drug delivery, with future progress expected to focus on adaptive, multifunctional, and patient-specific platforms that align with the principles of personalized medicine.

Ashna Sureshkumar, Prakash Balu · 0 citations
Review Open access 2026

The evolution of active targeting in cancer therapy: bridging molecular biomarkers and intelligent nanomedicine

The mini-review outlines the development of active targeting approaches, recent progress in the design of intelligent nanomedicine empowered by biomarkers, selected clinical advances, current clinical trials, and future prospects that could expedite the clinical translation of precision nanomedicine to the mainstream c...

M. Karthick, Rajesh Akkena, K. Loganathan · 0 citations
Review Open access Sep 2026

Next-generation nanomedicine for cancer therapy: advances, challenges, and future perspectives

This review paper provides an integrated and critical perspective on next-generation nanomedicine by connecting nanocarrier design with tumor-specific accumulation, intracellular trafficking, stimuli-responsive drug release, combination therapy and clinical translation.

Biswajit Mohanty, P. Saikia, Piyush Pandey et al. · 0 citations
Review Open access Aug 2026

Engineering strategies and translational progress in targeted nanoparticle drug delivery.

This review comprehensively examines major nanocarrier platforms, including lipid-based, polymeric, inorganic, and hybrid systems, with emphasis on their structural design and functional properties.

Nithya Ajay, Anu Shibi Anilkumar, R. Veerabathiran · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.